
Adrib Injection
Marketer
Adley Formulations
Salt Composition
Doxorubicin (Plain) (50mg)
Overview Adrib Injection
Adrib Injection treats various blood, breast, lung, ovarian, and soft tissue cancers. Administered intravenously by a healthcare professional, it may be used alone or in combination chemotherapy. Dosage and frequency are determined by your doctor and tailored to your specific condition, potentially varying over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse effects. While therapeutic benefits may not be immediate (weeks or months), discontinue use only as directed. Note that this medication reduces contraceptive efficacy; reliable birth control is advised for both partners throughout treatment. Common side effects include vomiting, nausea, allergic reactions, mouth sores, and hair loss. Report any concerning side effects to your physician; mitigation strategies may be available. This medication can lower blood cell counts, increasing infection risk, potentially life-threatening. Regular blood tests monitoring blood cell levels, kidney, liver, and heart function are essential. Prior to treatment, inform your doctor of any severe liver or heart conditions, pregnancy, breastfeeding, or other medications you are taking, as interactions may reduce Adrib's effectiveness or alter its action.
Uses of Adrib Injection
Malignant neoplasm
Major Benefits of Adrib Injection:
This medication will be administered by your physician or their qualified staff; self-medication is strictly prohibited.
Common Side effects of Adrib Injection:
- Vomiting
- Allergic reaction
- Nausea
- Mouth sore
- Hair loss
- Stomach pain
- Eye disorder
- Increased thirst
- Arrhythmia (irregular heartbeats)
- Nail disorder
How to use Adrib Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Adrib Injection works:
Adrib Injection is a cancer treatment that inhibits topoisomerase II, an enzyme crucial for cancer cell DNA replication. Its mechanism also involves generating damaging free radicals, leading to DNA disruption. This dual action restricts cancer cell proliferation, ultimately resulting in cell death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Adrib Injection hasn't been established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Adrib Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administration of Adrib Injection is contraindicated while breastfeeding due to the potential for infant toxicity.
DrivingUNSAFE
Adrib Injection may induce adverse reactions that impair driving ability. The common incidence of nausea and vomiting associated with Adrib Injection advises against operating a vehicle.
KidneySAFE IF PRESCRIBED
Adrib Injection poses no safety concerns for patients with kidney impairment; dosage modification is unnecessary. Nevertheless, disclosure of any kidney condition to your physician is advised.
LiverCAUTION
Individuals with hepatic impairment should use Adrib Injection cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Adrib Injection :
NA
Facts to Know About Adrib Injection
| Label | Value |
|---|---|
| Type of Compound | Anthracycline-based drug |
| Addictive | None. |
| Medication Classification | Cancer-fighting drugs |
| Mechanism of Action | Cytotoxic alkaloid compounds |
